GlassScriptPhysician profile
Philip Moraitis
NPI 1396730172
$2,289.52
in general payments reported to CMS, 2019-2025
20 companies · $539 in 2025
The $539 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $17.68 · 2021: $104 · 2022: $343 · 2023: $642 · 2024: $500 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $566.12 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $382.65 | 2019-2025 | Rocklatan, Tryptyr, Clareon |
| Tarsus Pharmaceuticals, INC. | $328.45 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $167.95 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $149.95 | 2023-2024 | Xiidra, Miebo, Vyzulta |
| Ocular Therapeutix, INC. | $104.14 | 2023-2025 | Dextenza |
| Sun Pharmaceutical Industries INC. | $83.87 | 2021-2025 | |
| Rxsight INC | $77.41 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Dompe US, INC. | $60.78 | 2025 | Oxervate |
| Abbvie INC. | $57.87 | 2022-2024 | |
| Horizon Therapeutics Plc | $53.92 | 2022-2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $46.50 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $44.59 | 2019 | |
| Thea Pharma INC. | $38.49 | 2022-2023 | Iyuzeh |
| E.R. Squibb & Sons, L.L.C. | $32.42 | 2024 | Camzyos |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $24.35 | 2025 | Hylenex Recombinant |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.25 | 2021 | |
| Allergan, INC. | $20.74 | 2021 | |
| Sight Sciences, INC. | $13.56 | 2019 | |
| Coopervision INC. | $13.51 | 2025 | Biofinity Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Moraitis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.